NewStem Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
NewStem Ltd. - overview
Established
2018
Location
Jerusalem, -, Israel
Primary Industry
Biotechnology
About
NewStem Ltd. is a technology transfer company dedicated to transforming innovative academic research from the Hebrew University of Jerusalem into commercial applications across various sectors, including AgTech and Medical Devices. NewStem Ltd. specializes in technology transfer, focusing on bringing groundbreaking academic research into the commercial realm.
Founded in 2018 in Jerusalem, Israel, the company has completed one significant deal to date. Ayelet Dilion-Mashiah is the CEO. In July 2018, NewStem Ltd. raised USD 4 mn in Seed funding led by Hollywood Media Corp.
, marking a pivotal point in their early operational phase. NewStem Ltd. , through its association with Yissum, the Hebrew University's technology transfer company, offers a diverse range of technologies aimed at addressing challenges in sectors such as AgTech, Chemistry, Nanotechnology, Computer Science, Medical Devices, Digital Health, and Pharmaceuticals. Their solutions cater to healthcare professionals, researchers, agricultural enterprises, and technology firms, with a focus on enhancing efficiency and fostering innovation in these industries.
The company actively markets its technologies to clients globally, including in Europe, North America, and Asia. NewStem Ltd. generates revenue primarily through collaborations with private companies, research institutions, and governmental entities. Their business model revolves around licensing agreements, joint ventures, and collaborative research, allowing clients access to their innovative technologies.
The terms of these agreements are tailored to the specific technology and partnership, enabling sustainable revenue streams through strategic alliances. NewStem Ltd. is planning to leverage its recent Seed funding of USD 4 mn, raised in July 2018, to support the development of new products aimed at expanding its portfolio in promising markets. The company is exploring opportunities to enter new geographic regions, particularly targeting growth in Europe and North America over the next few years.
The funding will also facilitate enhanced research collaborations and partnerships to accelerate their product development processes.
Current Investors
Hollywood Media Corp.
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Oncology/Cancer Treatment
Website
www.yissum.co.il
Verticals
HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
NewStem Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.